Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Immunomedics Inc (NASDAQ:IMMU)

2.68
Delayed Data
As of Jul 22
 +0.09 / +3.47%
Today’s Change
1.50
Today|||52-Week Range
5.44
-12.70%
Year-to-Date
No recent news for Immunomedics Inc.

Today’s Trading

Previous close2.59
Today’s open2.59
Day’s range2.57 - 2.75
Volume1,431,053
Average volume (3 months)1,990,516
Market cap$254.1M
Dividend yield--
Data as of 3:59pm ET, 07/22/2016

Growth & Valuation

Earnings growth (last year)-21.43%
Earnings growth (this year)-8.82%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)-37.48%
P/E ratioNM
Price/Sales67.02
Price/Book--

Competitors

 Today’s
change
Today’s
% change
AXGNAxoGen Inc-0.03-0.45%
ENTLEntellus Medical Inc+0.46+2.62%
IRIXIRIDEX Corp+0.36+2.28%
FONRFonar Corp-0.07-0.30%
Data as of 3:59pm ET, 07/22/2016

Financials

Next reporting dateAugust 18, 2016
EPS forecast (this quarter)-$0.11
Annual revenue (last year)$5.7M
Annual profit (last year)-$48.0M
Net profit margin-849.13%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Chief Scientific &
Patent Officer
David M. Goldenberg
President, Chief Executive Officer &
Director
Cynthia L. Sullivan
Corporate headquarters
Morris Plains, New Jersey

Forecasts

Partner Offers

Search for Jobs